Barington Capital Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-76,809
Closed -$4.16M 12
2023
Q1
$4.16M Sell
76,809
-25,151
-25% -$1.46M 5.68% 7
2022
Q4
$6.1M Sell
101,960
-20,000
-16% -$1.09M 9.12% 6
2022
Q3
$5.52M Sell
121,960
-84,114
-41% -$4.21M 11.03% 3
2022
Q2
$9.19M Buy
206,074
+3,771
+2% +$193K 13.91% 4
2022
Q1
$11.4M Buy
202,303
+20,616
+11% +$1.08M 13.78% 4
2021
Q4
$9.43M Buy
181,687
+151,268
+497% +$7.8M 9.42% 6
2021
Q3
$1.82M Sell
30,419
-1,006
-3% -$63.3K 1.89% 9
2021
Q2
$1.95M Hold
31,425
1.82% 9
2021
Q1
$2.05M Buy
31,425
+12,570
+67% +$820K 2.16% 9
2020
Q4
$1.24M Buy
+18,855
New +$1.11M 1.8% 9

Other funds holding EHC

Barington Capital Group's EHC Position: Q2 2023 in Review

Barington Capital Group sold out of Encompass Health (EHC) in Q2 2023, closing a stake of 76,809 shares — an estimated $4.16M sold.

Barington Capital Group first reported a position in EHC in Q4 2020 and held it in 10 quarters. The position peaked at $11.4M in Q1 2022. 387 funds tracked by Wall St. Rank hold EHC as of Q2 2023.

  • Barington Capital Group reported no remaining Encompass Health position as of Q2 2023 after selling out during the quarter.
  • Barington Capital Group sold 76,809 Encompass Health shares in Q2 2023, an estimated $4.16M.
  • Barington Capital Group first reported a position in Encompass Health in Q4 2020 and held it in 10 quarters.
  • Barington Capital Group's Encompass Health position peaked at $11.4M in Q1 2022.
  • 387 funds tracked by Wall St. Rank held Encompass Health as of Q2 2023.

Based on Barington Capital Group's 13F filing for Q2 2023, filed 14 Aug 2023.